Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 5;26(11):525–529. doi: 10.1002/clc.4960261110

Practicability and limitations of enhanced external counterpulsation as an additional treatment for angina

Dierk Werner 1, Joachim Kropp 2, Sebastian Schellong 3, Chris Friedel 3, Jens‐Uwe Voigt 1, Josef Ludwig 1, Werner G Daniel 1,, Frank A Flachskampf 1
PMCID: PMC6654601  PMID: 14640469

Abstract

Background: An increasing number of clinical studies indicates reduction of angina and myocardial ischemia by enhanced external counterpulsation (EECP) therapy. However, given the wide range of contraindications and the long duration of treatment, eligibility and practicality issues have not been addressed systematically.

Hypothesis: Of all candidates for EECP (patients with drug‐refractory angina without possibility of revascularization), the majority either have contraindications or have practical problems complying with the time demands that this therapy imposes. In the rest, EECP leads to satisfactory results.

Methods: During 18 months, every consecutive patient with angina despite medical and interventional therapy was evaluated for EECP at one center. Treated patients underwent a bicycle exercise test and perfusion imaging before and after the standard course of 35 h of EECP. In addition, patients were asked about frequency of angina and nitroglycerin usage before and after EECP, and all patients filled out a final questionnaire 1 year after the end of therapy.

Results: Overall, 48 patients were considered candidates for EECP. Of these, 24 were excluded for medical reasons: poor ejectionfraction (4), peripheral artery disease (4), anticoagulation (4), and atrial fibrillation (3). Eight further patients declined EECP for lack of time or accommodation. Another 3 of the 16 remaining patients dropped out because of side effects. In the 13 patients who finished the treatment course, weekly anginal episodes were reduced by 48% (p < 0.05), on‐demand nitroglycerin puffs were reduced by 51% (p<0.05), work capacity was improved by 22% (p <0.05), and the number of reversible perfusion defects in perfusion scans decreased non‐significantly (‐28%). However, 4 of 13 treated patients determined 1 year later that the detriment of loss of time exceeded the benefits of EECP.

Conclusion: Similar to previous reports, our study confirms the reduction of angina and improvement of work capacity after EECP. However, using established contraindications, approximately two‐thirds of patients considered to be candidates had to be excluded, and one‐third of the treated patients regarded EECP therapy retrospectively as too time consuming.

Keywords: enhanced external counterpulsation, angina, working capacity, contraindications

Full Text

The Full Text of this article is available as a PDF (35.8 KB).

References

  • 1. Zheng ZS, Li T, Kambic H, Chen G, Yu L, Cai S, Zhan C, Chen Y, Wo S, Chen G, Ma H, Chen P, Huang B, Nose Y: Sequential external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs 1983; 29: 599–603 [PubMed] [Google Scholar]
  • 2. Soroff HS, Hui J, Ciron F: Current status of external counterpulsation. Crit Care Clin 1986; 2: 277–295 [PubMed] [Google Scholar]
  • 3. Xu Y, Hu D, Zheng ZS: External counterpulsation. Chin Med J 1990; 103: 768–771 [PubMed] [Google Scholar]
  • 4. Lawson WE, Hui JCK, Soroff HS, Zheng ZS, Kayden DS, Sasvary D, Atkins H, Cohn PF: Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol 1992; 70: 859–862 [DOI] [PubMed] [Google Scholar]
  • 5. Arora RR, Chou, TM , Jain D, Fleishman B, Crawford L, McKiernan T, Nesto RW: The multicenter study of enhanced external counterpulsation (MUST‐EECP): Effect of EECP on exercise induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999; 33: 1833–1840 [DOI] [PubMed] [Google Scholar]
  • 6. Masuda D, Nohara R, Hirai T, Kataoka K, Chen LG, Hosokawa R, Inubushi M, Tadamura E, Fujitia M, Sasayama S: Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Eur Heart J 2001; 22: 1451–1458 [DOI] [PubMed] [Google Scholar]
  • 7. Karim S, Sani A, Karo‐Karo S, Kasim M, Basha A, Gunadhi I, Japaries W, Suwita R: Enhanced external counterpulsation in the treatment and rehabilitation of coronary patients in Indonesia. Asian Cardiovasc Thorac Ann 1995; 3: 26–28 [Google Scholar]
  • 8. Brown AS, Dodd D, Hevey D, Horgan JH: Enhanced external counterpulsation reduces angina frequency and improves exercise tolerance in patients with refractory angina (abstr). Heart 2000; 83 (suppl. 1): 4 [Google Scholar]
  • 9. Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T: Enhanced external counterpulsation improves exercise induced tolerance, reduces exercise‐induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol 2001; 37: 93–99 [DOI] [PubMed] [Google Scholar]
  • 10. Werner D, Hui JCK, Kropp J, Daniel WG: Pneumatische externe Gegenpulsation—Therapieoption bei Angina pectoris. Z Kardiol 1998; 87 (suppl. II): 193–198 [DOI] [PubMed] [Google Scholar]
  • 11. Suresh K, Simandl S, Lawson WE, Hui JCK, Lillis O, Burger L, Guo T, Cohn PF: Maximizing the hemodynamic benefit of enhanced external counterpulsation. Clin Cardiol 1998; 21: 649–653 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Cohn PF: EECP—new data on possible mechanisms of action. Eur Heart J 2001; 22: 1363–1364 [DOI] [PubMed] [Google Scholar]
  • 13. Conti CR: Alternative therapies for patients with persistent chronic stable angina. Clin Cardiol 1999; 22: 773–774 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Huang W, Chen YC, Zheng ZS, Zhong WF, Lawson WE, Hui JCK: External counterpulsation increases capillary density during experimental myocardial infarction (abstr). Eur Heart J 1999; 20 (suppl. 1): 168 [Google Scholar]
  • 15. Lawson WE, Hui JCK, Zheng ZS, Burger L, Jiang L, Lillis O, Oster Z, Soroff H, Cohn PF: Improved exercise tolerance following enhanced external counterpulsation: Cardiac or peripheral effect. Cardiology 1996; 87: 271–275 [DOI] [PubMed] [Google Scholar]
  • 16. Werner D, Wonka F, Krinke HE, Klinghammer L, Daniel WG: Pneumatische externe Gegenpulsation—ein neues perfusionstechnisches Prinzip. Biomed Tech 1998; 43 (suppl. 1): 344–345 [DOI] [PubMed] [Google Scholar]
  • 17. Cai D; Wu R, Shao Y: Experimental study of the effect of external counterpulsation on blood circulation in the lower extremities. Clin Invest Med 2000; 23: 239–247 [PubMed] [Google Scholar]
  • 18. Taguchi I, Ogawa K, Oida A, Abe S, Kaneko N, Sakio H: Comparison of hemodynamic effects of enhanced external counterpulsation and intra‐aortic balloon pumping in patients with acute myocardial infarction. Am J Cardiol 2000; 86: 1139–1141 [DOI] [PubMed] [Google Scholar]
  • 19. Lawson WE, Kennard ED, Holubkov R, Kesley SF, Strobeck JE, Soran O, Feldbeck AM, IEPR investigators : Benefit and safety of enhanced external counterpulsation in treating coronary artery disease patients with a history of congestive heart failure. Cardiology 2001; 96: 78–84 [DOI] [PubMed] [Google Scholar]
  • 20. Gorcsan J, Crawford L, Soran O, Wang H, Severyn D, de Lame PA, Schneider V: Improvement in left ventricular performance by enhanced external counterpulsation in patients with heart failure (abstr). J Am Coll Cardiol 2000; 35: 230 10636285 [Google Scholar]
  • 21. Stefanadis C, Dernellis J, Tsiamis E, Stratos C, Kallikazaros I, Toutouzas P: Aortic function in patients during intra‐aortic balloon pumping determined by the pressure‐diameter relation. J Thorac Cardiovasc Surg 1998; 116: 1052–1059 [DOI] [PubMed] [Google Scholar]
  • 22. Werner D, Schneider M, Weise M, Nonnast‐Daniel B, Daniel WG: Pneumatic external counterpulsation—a new non‐invasive method to improve organ perfusion. Am J Cardiol 1999; 84: 950–952 [DOI] [PubMed] [Google Scholar]
  • 23. Michaels AD, Kennard ED, Kelsey SE, Holubkov R, Soran O, Spence S, Chou TM: Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation? Data from the International EECP Patient Registry (IEPR). Clin Cardiol 2001; 24: 453–456 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Conti CR: EECP—Enhanced external counterpulsation. J Am Coll Cardiol 1999; 33: 1841–1842 [DOI] [PubMed] [Google Scholar]
  • 25. Stys TP, Lawson WE, Hui JCK, Fleishman B, Manzo K, Strobeck JE, Tartaglia J, Ramasamy S, Suwita R, Zheng ZS, Liang H, Werner D: Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol 2002; 89: 822–824 [DOI] [PubMed] [Google Scholar]
  • 26. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKierman T, Nesto R, Ferrans CE, Keller S: Effects of enhanced external counterpulsation on health‐related quality of life continue 12 months after treatment: A substudy of the multicenter study of enhanced external counterpulsation. J Invest Med 2002; 50: 25–32 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES